Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc/ US74112D1019 /
PBH
19/09/2024 22:10:00
|
Diferencia
+0.39
|
Volumen |
Bid10:09:57 |
Ask10:09:57 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
73.92USD
|
+0.53%
|
201,543 Volumen de negocios: 9.15 millones |
65.89Volumen de oferta: 100 |
118.27Tamaño/ Volumen/ Formato de Ask: 200 |
3.66 mil millonesUSD |
- |
17.56 |
Descripción de negocio
Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
Consejo de gestión & Consejo de supervisión
CEO |
Ron Lombardi |
Consejo de gestión |
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool |
Consejo de supervisión |
Ron Lombardi, Dawn M. Zier, Dr. Celeste A. Clark, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins, John F. Kelly |
Datos de la empresa
Nombre: |
Prestige Consumer Healthcare, Inc. |
Dirección: |
660 White Plains Road,Tarrytown, New York 10591, USA |
Teléfono: |
+1-914-524-6800 |
Fax: |
- |
E-mail: |
Irinquiries@prestigebrands.com
|
Internet: |
www.prestigebrandsinc.com/ |
Industria: |
Consumer Goods |
Sector: |
Cosmetics |
Subsector: |
Cosmetics |
Fin del año financiero: |
31/03 |
Acciones de libre circulación: |
- |
Fecha de OPI: |
- |
Accionistas mayoritarios
Freefloat |
|
69.88% |
BlackRock, Inc. |
|
12.50% |
The Vanguard Group |
|
10.72% |
Dimensional Fund Advisors LP |
|
6.90% |